NAHL Group plc
("NAHL" or the "Group")
Interim Results
NAHL, the leading UK marketing and services business focused on the UK consumer legal market, announces its Interim Results for the six months ended 30 June 2017.
Financial Highlights
· Revenue of £24.9m (2016 H1: £25.8m)
· Underlying operating profit of £7.3m (2016 H1: £8.8m)
· Underlying operating profit margin of 29.5% (2016 H1: 34.0%)
· Profit before tax of £5.3m after £1.0m brand repositioning charge in Personal Injury ("PI") business (2016 H1: £7.5m)
· Basic earnings per share of 9.0p (2016 H1: 13.2p)
· Interim dividend of 5.3p per share (2016 H1: 6.35p)
Operational Highlights
· PI division brand relaunch for NAH
· Successful establishment of Alternative Business Structure ("ABS") venture with NewLaw
· Strong margin performance from Residential Property division
· Critical Care division continues to perform well with new strategic business opportunities being pursued
Russell Atkinson, CEO of NAHL, commented:
"The first half of 2017 has been a busy period for the Group across all of its divisions and performance is in line with our expectations. We have relaunched the National Accident Helpline in our PI division and have been working hard to deliver our first ABS structure, with NewLaw, which began shortly after the period end. Initial signs are encouraging and we are working to deliver the second ABS by the end of the year.
"The Group's Residential Property and Critical Care divisions have made good progress year on year and we expect this to continue through the second half.
"Second half trading has continued in line with our expectations. We will further develop our PI proposition and explore enhanced PLF arrangements, driving increased volumes with our refreshed marketing plans. As previously reported, we expect both 2017 and 2018 to be years of transition in PI however we expect this to be complemented by growth in both Residential Property and Critical Care."
Enquiries:
NAHL Group plc Russell Atkinson (CEO) Steve Dolton (CFO)
|
via FTI Consulting Tel: +44 (0) 20 3727 1000 |
Investec Bank plc (NOMAD & Broker) Garry Levin David Flin James Ireland David Anderson William Godfrey
|
Tel: +44 (0) 20 7597 5970 |
FTI Consulting (Financial PR) Oliver Winters Alex Beagley James Styles
|
Tel: +44 (0) 20 3727 1000 |
Notes to Editors
NAHL Group plc is a leading UK marketing and services business focused on the UK consumer legal market. The Group comprises three divisions: Personal Injury (National Accident Helpline - NAH), Conveyancing (Fitzalan Partners - Fitzalan) and Ctitical Care (Bush & Company Rehabilitation - Bush). NAH provides outsourced marketing services in the personal injury market, Fitzalan, which includes Searches UK a leading conveyancing search provider, provides marketing services in the property market and Bush provides a range of specialist services in the catastrophic injury market.
More information is available at www.nahlgroupplc.co.uk and www.national-accident-helpline.co.uk
Chairman's Statement
I am pleased to report the Group's results for the six months ended 30 June 2017.
Summary of Financial Performance
NAHL Group plc ("NAHL" or "the Group") has performed in line with our expectations, with revenue at £24.9m (2016 H1: £25.8m), delivering underlying operating profit of £7.3m (2016 H1: £8.8m). After a charge of £1.0m for brand repositioning in our Personal Injury ("PI") business, profit before tax is £5.3m (2016 H1: £7.5m), with basic earnings per share of 9.0p (2016 H1: 13.2p).
Trading Review
National Accident Helpline ("NAH"), the Group's PI division, has performed in line with plan.
During the period we have continued to prepare for the regulatory changes previously announced by the Ministry of Justice. These changes are currently scheduled for implementation in October 2018, although we anticipate further delay. However we are satisfied that any delay will not significantly impact on the earnings profile of our business.
Our preparation for these changes includes a brand relaunch for NAH, the establishment of our first Alternative Business Structure ("ABS"), continued investment in cases with our strategic Panel Law Firm ("PLF") partners, and work on a second ABS. Good progress has been made on all these initiatives.
Our brand relaunch in June 2017 was designed to support NAH's PI market leadership, and help us generate enhanced enquiry volumes as we seek to invest in cases to optimise future earnings. Early indications from the relaunch are positive and we will continue to closely monitor the key metrics going forward.
The establishment of the Group's first ABS with NewLaw in July 2017 allows NAHL to have an ownership interest in a company providing legal services. This enables the Group to enter into a form of joint venture agreement to fund that venture and take a share of profit from work processed by the ABS. Whilst this new structure is in its infancy, the Group has delivered the agreed volumes and the initial signs are encouraging and in line with our expectations.
Investment in cases with PLFs and through our ABS ventures changes our medium term profit and cash profiles as we build the number of cases in progress, and is the primary reason behind the reduction in Group profits in the current year.
Both Fitzalan and Bush, the Group's Residential Property and Critical Care divisions, have made good progress year on year and we expect this to continue for the balance of 2017.
Fitzalan delivered revenue of £4.5m, down 3.1% on H1 2016 reflecting challenging market conditions, but profit before tax increased 17.9% to £0.8m. Whilst residential property markets remain challenging in volume terms, the division has delivered a strong performance with its mix of conveyancing, surveys and searches, and a focus on cost and efficiency of delivery has improved overall margins.
Bush delivered revenue of £5.6m, up 6.3% on H1 2016, with profit before tax of £2.0m, up 10.2%. Enquiry volumes have remained strong and we have a number of interesting strategic business development opportunities. These opportunities reflect the continued delivery of the high quality services for which the business is recognised.
Cash Conversion, Balance Sheet and Interim Dividend
Cash generation was as expected across the Group, with a 72.8% (2016 H1: 95.7%) cash conversion of underlying operating profit from continuing operations into net cash flows from operating activities before interest and tax. This decline reflects the investment in PI cases, with a corresponding increase in trade receivables on the balance sheet, but is buoyed by continued strong generation in our Residential Property and Critical Care divisions. Increased investment in PI cases in H2 will result in a lower cash conversion in the second half of the year.
The Group's balance sheet continues to be healthy and at the period end we had adjusted net debt of £11.5m (including £2.0m of other payables relating to the legacy pre-LASPO ATE product). Since the period end we have refinanced and significantly increased our banking facilities to support our long-term business strategy and in particular to help finance our investment in PI PLF and ABS cases.
Our dividend policy of 1.5x cover is unchanged. The Board has declared an interim dividend of 5.3p per share payable on 31 October 2017 to ordinary shareholders registered on 29 September 2017.
Outlook
Second half trading has commenced in line with our expectations. We will continue to develop our PI proposition and explore enhanced PLF arrangements, driving increased volumes with our refreshed marketing plans. As previously reported, we expect both 2017 and 2018 to be years of transition in PI however we expect this to be complemented by growth in both Residential Property and Critical Care.
Steve Halbert
Chairman
19 September 2017
Consolidated statement of comprehensive income
for the 6 months ended 30 June 2017
|
Note |
Unaudited 6 months ended 30 June 2017 £000 |
Unaudited 6 months ended 30 June 2016 £000 |
Audited 12 months ended 31 December 2016 £000 |
|
|
|
|
|
Underlying revenue |
2 |
24,930 |
25,753 |
49,385 |
One-off items |
|
- |
- |
1,250 |
Total revenue |
|
24,930 |
25,753 |
50,635 |
Cost of sales |
|
(12,014) |
(10,991) |
(20,809) |
Underlying gross profit |
|
12,916 |
14,762 |
28,576 |
One-off items |
|
- |
- |
1,250 |
Gross profit |
|
12,916 |
14,762 |
29,826 |
Administrative expenses |
|
(7,504) |
(7,034) |
(13,665) |
Underlying operating profit |
|
7,347 |
8,750 |
17,985 |
Share-based payments |
|
(281) |
(433) |
(1,052) |
Amortisation of intangible assets acquired on business combinations |
8 |
(654) |
(533) |
(1,327) |
One-off items |
5 |
(1,000) |
(56) |
555 |
Total operating profit |
2 |
5,412 |
7,728 |
16,161 |
Financial income |
3 |
38 |
10 |
43 |
Financial expense |
4 |
(166) |
(209) |
(403) |
Profit before tax |
|
5,284 |
7,529 |
15,801 |
Taxation |
|
(1,187) |
(1,563) |
(3,577) |
Profit for the year and total comprehensive income |
|
4,097 |
5,966 |
12,224 |
All profits and losses and total comprehensive income are attributable to the owners of the Company.
|
|
Unaudited 6 months ended 30 June 2017 |
Unaudited 6 months ended 30 June 2016 |
Audited 12 months ended 31 December 2016 |
Basic earnings per share (p) |
11 |
9.0 |
13.2 |
27.0 |
Diluted earnings per share (p) |
11 |
8.9 |
12.9 |
26.5 |
Consolidated statement of financial position
At 30 June 2017
|
Note |
Unaudited 6 months ended 30 June 2017 £000 |
Unaudited 6 months ended 30 June 2016 £000 |
Audited 12 months ended 31 December 2016 £000 |
Non-current assets |
|
|
|
|
Goodwill |
7 |
60,362 |
60,362 |
60,362 |
Intangibles |
8 |
7,783 |
8,780 |
8,474 |
Property, plant and equipment |
|
290 |
339 |
327 |
Deferred tax asset |
|
38 |
68 |
38 |
|
|
68,473 |
69,549 |
69,201 |
Current assets |
|
|
|
|
Trade and other receivables |
|
14,142 |
9,235 |
10,287 |
Cash and cash equivalents |
|
799 |
6,522 |
4,814 |
|
|
14,941 |
15,757 |
15,101 |
Total assets |
|
83,414 |
85,306 |
84,302 |
Current liabilities |
|
|
|
|
Other interest-bearing loans and borrowings |
|
(3,693) |
(3,693) |
(3,693) |
Trade and other payables |
|
(9,360) |
(9,557) |
(7,631) |
Other payables relating to legacy pre-LASPO ATE product |
2 |
(2,026) |
(3,167) |
(1,912) |
Deferred tax liability |
|
(1,914) |
(1,916) |
(1,914) |
Tax payable |
|
(1,432) |
(1,909) |
(1,937) |
|
|
(18,425) |
(20,242) |
(17,087) |
Non-current liabilities |
|
|
|
|
Other interest-bearing loans and borrowings |
|
(6,550) |
(9,243) |
(7,396) |
Total liabilities |
|
(24,975) |
(29,485) |
(24,483) |
Net assets |
|
58,439 |
55,821 |
59,819 |
Equity |
|
|
|
|
Share capital |
9 |
114 |
113 |
113 |
Share option reserve |
|
2,220 |
1,554 |
1,939 |
Share premium |
|
14,507 |
14,271 |
14,507 |
Merger reserve |
|
(66,928) |
(66,928) |
(66,928) |
Retained earnings |
|
108,526 |
106,811 |
110,188 |
Total equity |
|
58,439 |
55,821 |
59,819 |
Consolidated statement of changes in equity
for the 6 months ended 30 June 2017
|
Share capital £000 |
Share option reserve £000 |
Share premium £000 |
Merger reserve £000 |
Retained earnings £000 |
Total equity £000 |
Balance at 1 January 2017 |
113 |
1,939 |
14,507 |
(66,928) |
110,188 |
59,819 |
Total comprehensive income for the period |
|
|
|
|
|
|
Profit for the period |
- |
- |
- |
- |
4,097 |
4,097 |
Total comprehensive income |
- |
- |
- |
- |
4,097 |
4,097 |
Transactions with owners, recorded directly in equity |
|
|
|
|
|
|
Issue of new Ordinary Shares (note 10) |
1 |
- |
- |
- |
- |
1 |
Share-based payments |
- |
281 |
- |
- |
- |
281 |
Dividends paid |
- |
- |
- |
- |
(5,759) |
(5,759) |
Balance at 30 June 2017 |
114 |
2,220 |
14,507 |
(66,928) |
108,526 |
58,439 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at 1 January 2016 |
113 |
1,121 |
14,262 |
(66,928) |
106,503 |
55,071 |
Total comprehensive income for the period |
|
|
|
|
|
|
Profit for the period |
- |
- |
- |
- |
5,966 |
5,966 |
Total comprehensive income |
- |
- |
- |
- |
5,966 |
5,966 |
Transactions with owners, recorded directly in equity |
|
|
|
|
|
|
Issue of new Ordinary shares (note 10) |
- |
- |
9 |
- |
- |
9 |
Share-based payments |
- |
433 |
- |
- |
- |
433 |
Dividends paid |
- |
- |
- |
- |
(5,658) |
(5,658) |
Balance at 30 June 2016 |
113 |
1,554 |
14,271 |
(66,928) |
106,811 |
55,821 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at 1 January 2016 |
113 |
1,121 |
14,262 |
(66,928) |
106,503 |
55,071 |
Total comprehensive income for the year |
|
|
|
|
|
|
Profit for the year |
- |
- |
- |
- |
12,224 |
12,224 |
Total comprehensive income |
- |
- |
- |
- |
12,224 |
12,224 |
Transactions with owners, recorded directly in equity |
|
|
|
|
|
|
Issue of new Ordinary Shares (note 10) |
- |
- |
160 |
- |
- |
160 |
Exercise of share options (note 10) |
- |
(85) |
85 |
- |
- |
- |
Share-based payments |
- |
903 |
- |
- |
- |
903 |
Dividends paid |
- |
- |
- |
- |
(8,539) |
(8,539) |
Balance at 31 December 2016 |
113 |
1,939 |
14,507 |
(66,928) |
110,188 |
59,819 |
Consolidated cash flow statement
for the period ended 30 June 2017
|
Note |
Unaudited 6 months ended 30 June 2017 £000 |
Unaudited 6 months ended 30 June 2016 £000 |
Audited 12 months ended 31 December 2016 £000 |
Cash flows from operating activities |
|
|
|
|
Profit for the period/year |
|
4,097 |
5,966 |
12,224 |
Adjustments for: |
|
|
|
|
Depreciation and amortisation |
|
808 |
619 |
1,522 |
Financial income |
3 |
(38) |
(10) |
(43) |
Financial expense |
4 |
166 |
209 |
403 |
Share-based payments |
|
281 |
433 |
1,052 |
Taxation |
|
1,187 |
1,563 |
3,577 |
|
|
6,501 |
8,780 |
18,735 |
Increase in trade and other receivables |
|
(3,822) |
(823) |
(1,876) |
Increase in trade and other payables |
|
1,713 |
364 |
(1,868) |
Decrease in other payables relating to legacy pre-LASPO ATE product |
|
114 |
(434) |
(1,689) |
Cash generation from operations |
2 |
4,506 |
7,887 |
13,302 |
Interest paid |
|
(121) |
(209) |
(346) |
Tax paid |
|
(1,692) |
(1,735) |
(3,692) |
Net cash from operating activities |
|
2,693 |
5,943 |
9,264 |
Cash flows from investing activities |
|
|
|
|
Acquisition of property, plant and equipment |
|
(80) |
(151) |
(232) |
Consideration paid for the acquisition of subsidiaries |
|
- |
(2,091) |
(2,090) |
Intangible assets acquired |
|
- |
(14) |
(393) |
Cash acquired from business combinations |
|
- |
293 |
295 |
Interest received |
|
5 |
10 |
43 |
Net cash used in investing activities |
|
(75) |
(1,953) |
(2,377) |
Cash flows from financing activities |
|
|
|
|
New share issue |
|
1 |
9 |
160 |
Repayment of borrowings |
|
(1,875) |
(1,875) |
(3,750) |
New borrowings acquired |
|
1,000 |
- |
- |
Dividends paid |
|
(5,759) |
(5,658) |
(8,539) |
Net cash used in financing activities |
|
(6,633) |
(7,524) |
(12,129) |
Net decrease in cash and cash equivalents |
|
(4,015) |
(3,534) |
(5,242) |
Opening cash and cash equivalents |
|
4,814 |
10,056 |
10,056 |
Cash and cash equivalents at period/year end |
|
799 |
6,522 |
4,814 |
Notes to the financial statements
1. Accounting policies
General Information
The half year results for the current and comparative period to 30 June have not been audited or reviewed by auditors pursuant to the Auditing Practices Board guidance of Review of Interim Financial Information.
These half year results do not comprise statutory accounts within the meaning of Section 434 of the Companies Act 2006. Statutory accounts for the year ended 31 December 2016 were approved by the Board of Directors on 20 March 2017 and delivered to the Registrar of Companies. The report of the auditors on those accounts was unqualified, did not contain an emphasis of matter paragraph and did not contain any statement under Section 498 of the Companies Act 2006.
Having made due enquiries the directors have a reasonable expectation that the Group has adequate resources to continue in operational existence for the foreseeable future. For this reason, they continue to adopt the going concern basis in preparing the condensed set of financial statements.
The condensed set of financial statements was approved by the Board of directors on 18th September 2017.
Basis of preparation
Statement of compliance
The half year results for the current and comparative period to 30 June have been prepared in accordance with IAS 34 Interim financial reporting as adopted by the EU and the AIM Rules of UK companies. They do not include all of the information required for full annual financial statements and should be read in conjunction with the financial statements of the Group for the year ended 31 December 2016, which have been prepared in accordance with IFRSs as adopted by the European Union.
Use of judgements and estimates
The preparation of financial statements in conformity with IFRSs requires management to make judgements and estimates that affect the application of accounting policies and the reported amounts of assets, liabilities, income and expenses. Actual results may differ from these estimates. Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the year in which the estimates are revised and in any future years affected.
The preparation of the condensed set of financial statements requires management to make judgements, estimates and assumptions that affect the application of accounting policies and reported amounts of assets and liabilities, income and expense. Actual results may differ from these estimates.
In preparing the condensed set of financial statements, the significant judgements made by management in applying the Group's accounting policies and the key sources of estimation uncertainty were of the same type as those that applied to the financial statements for the year ended 31 December 2016.
Significant accounting policies
The accounting policies used in the preparation of these interim financial statements for the 6 months ended 30 June 2017 are the accounting policies as applied to the Group's financial statements for the year ended 31 December 2016.
Use of non-GAAP measures
Underlying operating profit
The directors believe that underlying revenue, underlying operating profit, underlying operating cash and adjusted net debt provide additional useful information for shareholders on underlying trends and performance. These measures are used for performance analysis and are considered useful as they relate to the core underlying trading activities of the Group i.e. they reflect the current ongoing activities of the Group and do not include any items that relate to significant one-off projects that are not expected to recur or any items that relate to activities that are outside the normal course of trading (e.g. acquisitions or share based costs that are not directly related to the current operating performance of the Group). Underlying revenue, underlying operating profit, underlying operating cash and adjusted net debt are not defined by IFRS and therefore may not be directly comparable to other companies' adjusted revenue, profit, cash or debt measures. They are not intended to be a substitute for, or superior to, IFRS measurements of operating profit.
The adjustments made to reported revenue are:
One-off revenues - fees related to one-off revenues in relation to release of the ATE liability that are not expected to recur and are not related to the continuing core operations of the business.
The adjustments made to reported operating profit are:
IFRS 2 Share Based Payments - non-cash Group Income Statement charge for share based payments and related national insurance costs. IFRS 2 requires the fair value of equity instruments measured at grant date to be spread over the period during which the employees become unconditionally entitled to the options. This is a non-cash charge and has been excluded from underlying operating profit as it does not reflect the underlying core trading performance of the Group.
IFRS 3 (Revised) Business Combinations - intangible asset amortisation charges and costs arising from acquisitions. Under IFRS 3 intangible assets are required to be amortised on a straight-line basis over their useful economic life and as such this is a non-cash charge that does not reflect the underlying performance of the business acquired. Similarly, the standard requires all acquisition costs to be expensed in the Group Income Statement. Due to their nature, these costs have been excluded from underlying operating profit as they do not reflect the underlying core trading performance of the Group.
One-off costs - these relate to certain one-off costs associated with the Group's acquisition activities including any costs in relation to aborted acquisitions, reorganisation costs associated with one-off projects that are not related to the core operations of the business and one-off income for the release of previously recognised liability for pre-LASPO ATE. These have been excluded from underlying operating profit as they do not reflect the underlying core trading performance of the Group.
Adjusted net debt
The directors believe that the adjusted net debt provides additional useful information for shareholders on underlying trends and performance. This measure is used for performance analysis. Adjusted net debt is not defined by IFRS and therefore may not be directly comparable with other companies' adjusted debt measures. It is not intended to be a substitute for, or superior to, IFRS measurements of net debt. Adjusted net debt comprises cash and cash equivalents, borrowings and other payables relating to a discontinued pre- LASPO product.
Business combinations
Business combinations are accounted for using the acquisition method as at the acquisition date, which is the date on which control is transferred to the Group. The Group measures goodwill as the acquisition-date fair value of the consideration transferred, less the net of the acquisition-date fair values of the identifiable assets acquired and liabilities assumed, including contingent liabilities as required by IFRS 3.
Consideration transferred includes the fair values of assets transferred, liabilities incurred by the Group to the previous owners of the acquiree, equity interests issued by the Group, contingent consideration, and share-based payment awards of the acquiree that are replaced in the business combination. Any contingent consideration payable is recognised at fair value at the acquisition date. Subsequent changes to the fair value of contingent consideration that is not classified as equity are recognised in the income statement.
Transaction costs that the Group incurs in connection with a business combination, such as finder's fees, legal fees, due diligence fees, and other professional and consulting fees, are expensed as incurred.
Goodwill
Goodwill represents the excess of the fair value of the consideration given over the fair value of the Group's share of the net identifiable assets of the acquired subsidiary at the date of acquisition. Goodwill is not amortised but is tested for impairment annually and again whenever indicators of impairment are detected and is carried at cost less any provision for impairment. Any impairment is recognised in the statement of comprehensive income.
Other intangible assets
Other intangible assets that are acquired by the Group and have finite useful lives are measured at cost less accumulated amortisation and any accumulated impairment losses.
Cost or valuation
Intangible assets arising from a business combination are recognised at fair value, amortised over their estimated useful lives and subject to impairment testing.
Amortisation
Intangible assets are amortised on a straight-line basis over their estimated useful lives as follows:
• Technology related intangibles - 5 to 10 years
• Contract related intangibles - 3 to 10 years
• Brand names - 3 to 10 years
• Other intangibles assets - 3 years
No amortisation is charged on assets under construction as these are not yet in use.
Depreciation
Depreciation is calculated to write off the cost, less estimated residual value, of property, plant and equipment by equal instalments over their estimated useful economic lives as follows:
• Office equipment - 3 to 5 years
• Computers - 3 years
2. Operating segments
|
Personal Injury £000 |
Pre-LASPO ATE £000 |
Critical Care £000 |
Residential Property £000 |
Other segments £000 |
One-off items £000 |
Total £000 |
Period ended 30 June 2017 |
|
|
|
|
|
|
|
Revenue |
14,854 |
- |
5,564 |
4,512 |
- |
- |
24,930 |
Depreciation and amortisation |
(91) |
- |
(32) |
(31) |
- |
(654) |
(808) |
Operating profit/(loss) |
5,371 |
- |
2,000 |
805 |
(829) |
(1,935) |
5,412 |
Financial income |
36 |
- |
- |
- |
2 |
- |
38 |
Financial expenses |
- |
- |
(2) |
- |
(164) |
- |
(166) |
Profit/(loss) before tax |
5,407 |
- |
1,998 |
805 |
(991) |
(1,935) |
5,284 |
Trade receivables |
4,117 |
- |
4,210 |
499 |
- |
- |
8,826 |
Segment liabilities |
(6,884) |
(2,026)* |
(885) |
(984) |
(492) |
(115) |
(11,386) |
Capital expenditure |
33 |
- |
27 |
20 |
- |
- |
80 |
|
|
|
|
|
|
|
|
Period ended 30 June 2016 |
|
|
|
|
|
|
|
Revenue |
15,864 |
- |
5,234 |
4,655 |
- |
- |
25,753 |
Depreciation and amortisation |
(39) |
- |
(18) |
(84) |
(478) |
- |
(619) |
Operating profit/(loss) |
7,005 |
- |
1,815 |
685 |
(755) |
(1,022) |
7,728 |
Financial income |
10 |
- |
- |
- |
- |
- |
10 |
Financial expenses |
- |
- |
(2) |
(2) |
(205) |
- |
(209) |
Profit/(loss) before tax |
7,015 |
- |
1,813 |
683 |
(960) |
(1,022) |
7,529 |
Trade receivables |
2,217 |
- |
3,510 |
541 |
130 |
- |
6,398 |
Segment liabilities |
(6,508) |
(3,167)* |
(1,131) |
(1,298) |
(620) |
- |
(12,724) |
Capital expenditure |
131 |
- |
15 |
5 |
- |
- |
151 |
|
|
|
|
|
|
|
|
Year ended 31 December 2016 |
|
|
|
|
|
|
|
Revenue |
30,011 |
1,250 |
10,353 |
9,021 |
- |
- |
50,635 |
Depreciation and amortisation |
(89) |
- |
(44) |
(147) |
- |
(1,242) |
(1,522) |
Operating profit/(loss) |
14,112 |
1,155 |
3,786 |
1,391 |
(1,304) |
(2,979) |
16,161 |
Financial income |
14 |
- |
19 |
- |
10 |
- |
43 |
Financial expenses |
(1) |
- |
(5) |
- |
(397) |
- |
(403) |
Profit/(loss) before tax |
14,125 |
1,155 |
3,800 |
1,391 |
(1,691) |
(2,979) |
15,801 |
Trade receivables |
1,935 |
- |
3,929 |
343 |
- |
- |
6,207 |
Segment liabilities |
(5,227) |
(1,982)* |
(1,035) |
(765) |
(503) |
(31) |
(9,543) |
Capital expenditure |
608 |
- |
96 |
46 |
- |
- |
750 |
*Pre-LASPO ATE liabilities include the balance of commissions received in advance that are due to be paid back to the insurance provider of £2,026,000 (June 2016: £3,167,000, December 2016: £1,912,000) and accruals for associated costs of £nil (June 2016: £nil, December 2016: £70,000).
Geographic information
All revenue and assets of the Group are based in the UK.
Operating segments
The segments used in reporting by the CODM and considered relevant to the business are segmented on a product basis. These
segments are:
Personal Injury
Revenue from the provision of enquiries to the Panel Law Firms, based on a cost plus margin model, plus commissions received from providers for the sale of additional products by them to the Panel Law Firms.
Pre-LASPO ATE
Revenue is commissions received from the insurance provider for the use of after the event policies by Panel Law
Firms. From 1 April 2013, this product was no longer available as a result of LASPO regulatory changes. Included in the balance
sheet is a liability that has been separately identified due to its material value. This balance is commissions received in advance
that are due to be paid back to the insurance provider. No interest is due on this liability.
Critical Care
Revenue from the provision of expert witness reports and case management support within the medico-legal framework for multi-track cases.
Residential Property
Revenue from the provision of online marketing services to target home buyers and sellers in England and Wales, offering lead generation services to Panel Law Firms and surveyors in the conveyancing sector and the provision of conveyancing searches for solicitors and licensed conveyancers.
Other segments
Costs that are incurred in managing Group activities or not specifically related to a product.
One-off items
Costs associated with the acquisition of subsidiary undertakings, reorganisation costs associated with one-off projects that are not related to the core operations of the business, release of ATE liability and including share based payments and amortisation charges on intangible assets recognised as part of business combinations.
Cash flows from operating activities
A reconciliation of operating profit to cash generation from operations has been presented below separately identifying net cash flows relating to Continuing operations (comprising cash flows associated with Personal Injury, Critical Care, Residential Property and other segments), the Pre- LASPO ATE product segment and one-off items.
Reconciliation of operating profit to net cash flows from operating activities
|
Continuing operations £000 |
Pre-LASPO ATE £000 |
Sub-total £000 |
Non underlying items £000 |
Total £000 |
6 months ended 30 June 2017 |
|
|
|
|
|
Operating profit |
6,412 |
- |
6,412 |
(1,000) |
5,412 |
Amortisation of intangible assets acquired on business combinations |
654 |
- |
654 |
- |
654 |
Equity-settled share-based payments |
281 |
- |
281 |
- |
281 |
Underlying operating profit |
7,347 |
- |
7,347 |
(1,000) |
6,347 |
Depreciation and amortisation |
154 |
- |
154 |
- |
154 |
(Increase) in trade/other receivables |
(3,822) |
- |
(3,822) |
- |
(3,822) |
Increase/(decrease) in trade/other payables |
1,668 |
(70) |
1,598 |
115 |
1,713 |
Increase in liabilities relating to pre-LASPO ATE product |
- |
114 |
114 |
- |
114 |
Net cash flows from operating activities before interest and tax |
5,347 |
44 |
5,391 |
(885) |
4,506 |
Interest paid |
(121) |
- |
(121) |
- |
(121) |
Tax paid |
(1,692) |
- |
(1,692) |
- |
(1,692) |
Net cash from operating activities |
3,534 |
44 |
3,578 |
(885) |
2,693 |
|
|
|
|
|
|
||||||
6 months ended 30 June 2016 |
|
|
|
|
|
||||||
Operating profit |
7,784 |
- |
7,784 |
(56) |
7,728 |
||||||
Amortisation of intangible assets acquired on business combinations |
533 |
- |
533 |
- |
533 |
||||||
Equity-settled share-based payments |
433 |
- |
433 |
- |
433 |
||||||
Underlying operating profit |
8,750 |
- |
8,750 |
(56) |
8,694 |
||||||
Depreciation and amortisation |
86 |
- |
86 |
- |
86 |
||||||
(Increase) in trade/other receivables |
(823) |
- |
(823) |
- |
(823) |
||||||
Increase in trade/other payables |
364 |
- |
364 |
- |
364 |
||||||
Decrease in liabilities relating to pre-LASPO ATE product |
- |
(434) |
(434) |
- |
(434) |
||||||
Net cash flows from operating activities before interest and tax |
8,377 |
(434) |
7,943 |
(56) |
7,887 |
||||||
Interest paid |
(209) |
- |
(209) |
- |
(209) |
||||||
Tax paid |
(1,735) |
- |
(1,735) |
- |
(1,735) |
||||||
Net cash from operating activities |
6,433 |
(434) |
5,999 |
(56) |
5,943 |
||||||
|
|
|
|
|
|
|||||
12 months ended 31 December 2016 |
|
|
|
|
|
|||||
Operating profit |
15,606 |
1,155 |
16,761 |
(600) |
16,161 |
|||||
Amortisation of intangible assets acquired on business combinations |
1,327 |
- |
1,327 |
- |
1,327 |
|||||
Equity-settled share-based payments |
1,052 |
- |
1,052 |
- |
1,052 |
|||||
Underlying operating profit |
17,985 |
1,155 |
19,140 |
(600) |
18,540 |
|||||
Depreciation and amortisation |
195 |
- |
195 |
- |
195 |
|||||
(Increase) in trade/other receivables |
(1,876) |
- |
(1,876) |
- |
(1,876) |
|||||
(Decrease)/Increase in trade/other payables |
(1,969) |
70 |
(1,899) |
31 |
(1,868) |
|||||
Decrease in liabilities relating to pre-LASPO ATE product |
- |
(1,689) |
(1,689) |
- |
(1,689) |
|||||
Net cash flows from operating activities before interest and tax |
14,335 |
(464) |
13,871 |
(569) |
13,302 |
|||||
Interest paid |
(346) |
- |
(346) |
- |
(346) |
|||||
Tax paid |
(3,692) |
- |
(3,692) |
- |
(3,692) |
|||||
Net cash from operating activities |
10,297 |
(464) |
9,833 |
(569) |
9,264 |
|||||
3. Financial income
|
Unaudited 6 months ended 30 June 2017 £000 |
Unaudited 6 months ended 30 June 2016 £000 |
Audited 12 months ended 31 December 2016 £000 |
Bank interest income |
5 |
10 |
25 |
Other interest income |
33 |
- |
- |
Investment income |
- |
- |
18 |
Total finance income |
38 |
10 |
43 |
4. Financial expense
|
Unaudited 6 months ended 30 June 2017 £000 |
Unaudited 6 months ended 30 June 2016 £000 |
Audited 12 months ended 31 December 2016 £000 |
On bank loans and overdrafts |
135 |
209 |
340 |
Bank charges |
31 |
- |
63 |
Total finance expense |
166 |
209 |
403 |
5. One-off items
|
Unaudited 6 months ended 30 June 2017 £000 |
Unaudited 6 months ended 30 June 2016 £000 |
Audited 12 months ended 31 December 2016 £000 |
Personal Injury reorganisation costs1 |
1,000 |
- |
522 |
Legal and professional fees relating to acquisitions 2 |
- |
56 |
78 |
Release of pre-LASPO ATE liability and associated costs3 |
- |
- |
(1,155) |
Total |
1,000 |
56 |
(555) |
1. Personal Injury reorganisation costs relate to costs associated with one-off projects that are not related to the core operations of the
business.
2. Legal and professional fees paid in relation to the acquisitions of Searches UK including due diligence costs and stamp duty.
3. Previously recognised liabilities for pre-LASPO ATE commissions received in advance of £1,250,000 were released in 2016 as a result of more favourable settlements. These have been offset by associated costs of £95,000.
6. Acquisitions
Acquisition of Searches UK Limited
On 11 January 2016 the Group acquired the entire share capital of Searches UK Limited. The company is a leading conveyancing search provider in England & Wales predominantly for residential property transactions.
Fair values
The acquisitions had the following effect on the Group's assets and liabilities:
|
|
Unaudited 6 months ended 30 June 2017 £000 |
Unaudited 6 months ended 30 June 2016 £000 |
Audited 12 months ended 31 December 2016 £000 |
Intangible assets |
|
- |
881 |
881 |
Tangible assets |
|
- |
6 |
6 |
Trade and other receivables |
|
- |
367 |
369 |
Cash and cash equivalents |
|
- |
293 |
295 |
Trade and other payables |
|
- |
(415) |
(419) |
Deferred tax liability |
|
- |
(176) |
(176) |
Net assets acquired |
|
- |
956 |
956 |
Goodwill arising on acquisition |
|
- |
1,124 |
1,124 |
Fair value of net assets acquired and goodwill arising |
|
- |
2,080 |
2,080 |
|
|
|
|
|
Cash consideration |
|
- |
2,080 |
2,080 |
Fair value of net assets acquired and goodwill arising |
|
- |
2,080 |
2,080 |
The Group incurred acquisition related costs of £78,000 for full year 2016 (H1 2016: £56,000) related to professional fees paid for due diligence, general professional fees and legal related costs. These costs have been included in one-off items in the Group's consolidated income statement.
For all acquisitions made in the year, fair values remain provisional, but will be finalised within 12 months of acquisition.
7. Goodwill
|
Personal Injury £000 |
Residential property £000 |
Critical Care £000 |
Total £000 |
Cost |
|
|
|
|
At 30 June 2016 |
39,897 |
4,873 |
15,592 |
60,362 |
At 30 December 2016 |
39,897 |
4,873 |
15,592 |
60,362 |
At 30 June 2017 |
39,897 |
4,873 |
15,592 |
60,362 |
Impairment |
|
|
|
|
At 30 June 2016 |
- |
- |
- |
- |
At 30 December 2016 |
- |
- |
- |
- |
At 30 June 2017 |
- |
- |
- |
- |
Net book value |
|
|
|
|
At 30 June 2016 |
39,897 |
4,873 |
15,592 |
60,362 |
At 30 December 2016 |
39,897 |
4,873 |
15,592 |
60,362 |
At 30 June 2017 |
39,897 |
4,873 |
15,592 |
60,362 |
8. Intangibles
|
Technology related £000 |
Contract related £000 |
Brand names £000 |
Other £000 |
Assets under construction £000 |
Total £000 |
Cost |
|
|
|
|
|
|
At 30 June 2016 |
167 |
8,466 |
885 |
57 |
8 |
9,583 |
At 31 December 2016 |
167 |
8,466 |
885 |
549 |
20 |
10,087 |
Additions |
- |
- |
- |
- |
23 |
23 |
At 30 June 2017 |
167 |
8,466 |
885 |
549 |
43 |
10,110 |
Amortisation |
|
|
|
|
|
|
At 30 June 2016 |
32 |
688 |
72 |
11 |
- |
803 |
At 31 December 2016 |
42 |
1,286 |
258 |
27 |
- |
1,613 |
Amortisation charge on business combinations |
10 |
538 |
106 |
- |
- |
654 |
Amortisation charge for the period |
- |
- |
- |
60 |
- |
60 |
At 30 June 2017 |
52 |
1,824 |
364 |
87 |
- |
2,327 |
Net book value |
|
|
|
|
|
|
At 30 June 2016 |
135 |
7,778 |
813 |
46 |
8 |
8,780 |
At 31 December 2016 |
125 |
7,180 |
627 |
522 |
20 |
8,474 |
At 30 June 2017 |
115 |
6,642 |
521 |
462 |
43 |
7,783 |
The intangible assets recognised were acquired as part of the acquisitions of Fitzalan, BVC, Bush and Searches UK.
9. Share capital
|
30 June 2017 |
30 June 2016 |
31 December 2016 |
Number of shares |
|
|
|
'A' Ordinary Shares of £0.0025 each |
45,511,088 |
45,270,937 |
45,349,629 |
|
|
|
|
|
£000 |
£000 |
£000 |
Allotted, called up and fully paid |
|
|
|
'A' Ordinary Shares of £0.0025 each |
114 |
113 |
113 |
|
|
|
|
Shares classified in equity |
114 |
113 |
113 |
10. Transactions with owners, recorded directly in equity
On 29 June 2017, 161,459 new ordinary shares with a par value of £0.0025 were issued due to the exercising of equity settled share based payments in respect of the LTIP scheme. These raised an additional £404 of funds for the Company, resulting in an increase to share capital of £404.
During 2016 84,629 share options were exercised which resulted in the issue of 84,629 new Ordinary Shares with a par value of
£0.0025. The exercising of these options raised funds of £160,508 for the Group. A charge of £85,093 has been reclassified from
the share option reserve to share premium to reflect the crystalisation of previous charges in respect of these options.
11. Basic earnings per share
The calculation of basic earnings per share at 30 June 2017 is based on profit attributable to ordinary shareholders of £4,097,000 (H1 2016: £5,966,000; Full Year 2016: £12,224,000) and a weighted average number of Ordinary Shares outstanding of 45,350,071 (June 2016: 45,266,598; December 2016: 45,294,877).
Profit attributable to ordinary shareholders (basic)
|
Unaudited 6 months ended 30 June 2017 £000 |
Unaudited 6 months ended 30 June 2016 £000 |
Audited 12 months ended 31 December 2016 £000 |
Profit for the period / year attributable to the shareholders |
4,097 |
5,966 |
12,224 |
Weighted average number of Ordinary Shares (basic)
Number |
|
Unaudited 6 months ended 30 June 2017 |
Unaudited 6 months ended 30 June 2016 |
Audited 12 months ended 31 December 2016 |
Issued Ordinary Shares at start of period |
|
45,349,629 |
45,265,000 |
45,265,000 |
Weighted average number of Ordinary Shares at end of period |
|
45,350,071 |
45,266,598 |
45,294,877 |
Basic earnings per share (p)
|
Unaudited 6 months ended 30 June 2017 |
Unaudited 6 months ended 30 June 2016 |
Audited 12 months ended 31 December 2017 |
Basic earnings per share (p) |
9.0 |
13.2 |
27.0 |
The Company has in place share-based payment schemes to reward employees. At the 30 June 2017, all necessary targets have been met and the LTIP scheme is at a value that would reasonably result in the options being exercised. The incremental shares available for these schemes included in the diluted earnings per share calculation are 602,503 (June 2016: 969,707; December 2016: 775,746). There are no other diluting items.
Diluted earnings per share (p)
|
Unaudited 6 months ended 30 June 2017 |
Unaudited 6 months ended 30 June 2016 |
Audited 12 months ended 31 December 2016 |
Diluted earnings per share (p) |
8.9 |
12.9 |
26.5 |
12. Financial risk management
The Group's financial risk management objectives and policies are consistent with those disclosed in the financial statements for the year ended 31 December 2016. At 1 January 2017 and 30 June 2017 the Group held all financial instruments at Level 3 (as defined in IFRS 7 Financial instruments: disclosures) and there have been no transfers of assets or liabilities between levels of the fair value hierarchy.
13. Net debt
Net debt includes cash and cash equivalents, secured bank loans, loan notes and preference shares.
|
30 June 2017 £000 |
30 June 2016 £000 |
31 December 2016 £000 |
Cash and cash equivalents |
799 |
6,522 |
4,814 |
Other interest-bearing loans and loan notes |
(10,243) |
(12,936) |
(11,089) |
Net debt |
(9,444) |
(6,414) |
(6,275) |
Set out below is a reconciliation of movements in net cash during the period.
|
30 June 2017 £000 |
30 June 2016 £000 |
31 December 2016 £000 |
Net decrease in cash and cash equivalents |
(4,015) |
(3,534) |
(5,242) |
Cash and cash equivalents net inflow from increase in debt and debt financing |
846 |
1,846 |
3,693 |
Movement in net borrowings resulting from cash flows |
(3,169) |
(1,688) |
(1,549) |
Movement in debt in period |
(3,169) |
(1,688) |
(1,549) |
Net debt at beginning of period |
(6,275) |
(4,726) |
(4,726) |
Net debt at end of period |
(9,444) |
(6,414) |
(6,275) |
During 2017 the Group made an initial drawdown of £1.0m on its rolling credit facility. The Group refinanced its bank facilities on the 8th September 2017 and as a result, it is the Group's intention to repay this in more than 12 months time and hence the £1.0m is deemed to be a non-current liability.
14. Related parties
Transactions with key management personnel
Key management personnel in situ at 30 June 2017 and their immediate relatives control 4.1 per cent (June 2016: 4.7 per cent, December 2016: 4.4 per cent) of the voting shares of the Company.
Key management personnel are considered to be the directors of the Company as well as those of National Accident Helpline Limited, Fitzalan Partners Limited, Bush & Company Rehabilitation Limited, Searches UK Limited and any other management serving as part of the executive team.